Table 2.
Univariate Cox proportional hazards analysis for risk of all‐cause mortality
| Item | Hazard ratio | 95% CI | P |
|---|---|---|---|
| Age (per 1 year increase) | 1.00 | 0.98–1.01 | 0.69 |
| Male | 1.16 | 0.73–1.94 | 0.53 |
| Body mass index (per 1 kg/m2 increase) | 0.9 | 0.87–0.936 | <0.001 |
| NYHA IV (vs. NYHA II or III) | 9.31 | 5.73–14.9 | <0.001 |
| Diabetes mellitus | 1.22 | 0.81–1.80 | 0.32 |
| Ischaemic cardiomyopathy | 1.22 | 0.81–1.81 | 0.33 |
| Atrial fibrillation | 1.74 | 1.14–2.61 | 0.011 |
| QRS duration >150 ms | 0.55 | 0.37–0.82 | 0.003 |
| VALID‐CRT risk score (per 1 increase) | 1.40 | 1.12–1.76 | 0.002 |
| Haemoglobin (per 1 g/dL increase) | 0.80 | 0.73–0.88 | <0.001 |
| Platelet count (per 1 × 103/μL increase) | 0.99 | 0.99–1.00 | 0.24 |
| Total bilirubin (per 0.1 mg/dL increase) | 1.00 | 0.66–1.45 | 0.98 |
| AST (per 10 U/L increase) | 0.95 | 0.81–1.00 | 0.37 |
| ALT (per 10 U/L increase) | 0.96 | 0.85–1.00 | 0.37 |
| GGT (per 10 U/L increase) | 1.00 | 0.98–1.02 | 0.40 |
| Sodium (per 1 mmol/L increase) | 0.91 | 0.86–0.96 | <0.001 |
| BUN (per 1 mg/dL increase) | 1.02 | 1.00–1.02 | <0.001 |
| Cr (per 0.1 mg/dL increase) | 1.01 | 0.99–1.01 | 0.052 |
| ln [NT‐proBNP] (per 1 increase) | 1.61 | 1.38–1.89 | <0.001 |
| MELD‐XI score (per 1 increase) | 1.04 | 1.01–1.07 | 0.002 |
| LVEDV (per 10 mL increase) | 1.00 | 0.97–1.02 | 0.96 |
| LVESV (per 10 mL increase) | 1.00 | 0.97–1.03 | 0.67 |
| LVEF (per 1% increase) | 0.98 | 0.96–1.00 | 0.066 |
| Moderate or severe MR | 1.26 | 0.78–1.96 | 0.32 |
| RVDd (per 1 mm increase) | 0.99 | 0.97–1.02 | 0.99 |
| RVFAC (per 1% increase) | 0.98 | 0.96–0.99 | 0.046 |
| Moderate or severe TR | 1.74 | 1.04–2.84 | 0.032 |
| TRPG (per 1 mmHg increase) | 1.02 | 1.01–1.04 | <0.001 |
| Maximal IVC diameter (per 1 mm increase) | 1.02 | 0.98–1.06 | 0.19 |
CI, confidence interval. Other abbreviations as in Table 1 .